OPKO Health Receives Core Technology U.S. Patent Allowance
OPKO Health, Inc. (NYSE: OPK) today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled “Structures for Controlling Light Interaction with Microfluidic Devices”.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.